Cyberonics Announces FDA Approval Of The AspireSR® Generator For VNS Therapy®

clinical trials for cancer

Cyberonics Announces FDA Approval Of The AspireSR® Generator For VNS Therapy®HOUSTON, June 2, 2015 /PRNewswire/ — Cyberonics, Inc. (NASDAQ: CYBX) today announced FDA approval of the AspireSR® generator for the VNS Therapy® System – the first and only VNS Therapy System that provides responsive stimulation to heart-rate increases that are often associated with seizures in people with epilepsy. read more

FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA

These data also served as the basis for the FDA Breakthrough Therapy designation for KEYTRUDA in advanced NSCLC. Merck has filed for approvalread more
The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019     DALLAS, June 3, 2015 /PRNewswire/ –According to a new market research report Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) – Forecasts to 2019 “, published by MarketsandMarkets, the Interventional Cardiology and Peripheral Vascular Devices Market is expected to reach around $26.72 Billion by 2019 with a CAGR of 7.4% from 2014 to 2019. read more

 

 

Get Med Career News in your Inbox!

If you want to keep up with the latest news and career tips in the Medical Field subscribe today!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.